EuroEyes completes EUR 131.35 million acquisition of EuroEyes Netherlands

• EuroEyes completed its acquisition of EuroEyes Netherlands on July 22, 2026, valuing the deal at EUR 131.35 million under a locked-box mechanism.
• EuroEyes funded EUR 118.63 million of the consideration; management vehicle Manco contributed EUR 12.73 million via a subscription alongside the transaction.
• Post-subscription, EuroEyes holds about 90.31% of EuroEyes Netherlands; Manco owns about 9.69%.
• EuroEyes reallocated HKD 152.49 million of unutilized IPO proceeds to support the European acquisition, shifting funds away from China clinic expansion and marketing.
• Remaining unutilized proceeds earmarked for working capital were HKD 64.56 million, with full utilization now targeted by July 22, 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euroeyes International Eye Clinic Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260723-12253238), on July 22, 2026, and is solely responsible for the information contained therein.